Table 1.

Baseline characteristics

Characteristic	rtCGM (n = 30)	isCGM (n = 30)	P value
Male, %	52	29	0.07
Age, years	39.6 ± 12.2	37.8 ± 12.7	0.31
BMI, kg/m2	26.0 ± 4.2	24.9 ± 3.7	0.28
Duration of diabetes, years	15.9 ± 11.4	14.4 ± 10.2	0.26
Microvascular complications, %	33	27	0.78
DKA during lifetime, %	27	30	0.99
Regular physical activity, %	27	23	0.99
MDI therapy, %	69	55	0.26
Total daily dose of insulin, units	47.2 ± 4.8	47.4 ± 16.5	0.98
Frequency of SMBG/day, n	4.4 ± 1.3	4.1 ± 0.9	0.55
HbA1c, mmol/mol	61.1 ± 10.7	63.5 ± 13.9	0.46
HbA1c, %	7.7 ± 1.0	8.0 ± 1.2	0.44
Gold score	2.1 ± 0.9	2.1 ± 1.0	0.52

Data are mean ± SD unless otherwise indicated.

DKA, diabetic ketoacidosis; SMBG, self-monitoring of blood glucose.